Related Experiment Videos
Synthetic fluoropeptides as pharmacologically useful compounds
1Department of Chemistry, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213.
Advances in Biotechnological Processes
|January 1, 1988
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Photophysics and biological applications of the environment-sensitive fluorophore 6-N,N-dimethylamino-2,3-naphthalimide.
Journal of the American Chemical Society·2005
Substrate specificity of the glycosyl donor for oligosaccharyl transferase.
The Journal of organic chemistry·2001
Oligomerization of uniquely folded mini-protein motifs: development of a homotrimeric betabetaalpha peptide.
Journal of the American Chemical Society·2001
Substrate specificity of N-acetylglucosaminyl(diphosphodolichol) N-acetylglucosaminyl transferase, a key enzyme in the dolichol pathway.
Bioorganic & medicinal chemistry·2001
Design of a discretely folded mini-protein motif with predominantly beta-structure.
Nature structural biology·2001
Probing the extended binding determinants of oligosaccharyl transferase with synthetic inhibitors of asparagine-linked glycosylation.
Bioorganic & medicinal chemistry letters·2000
Pertussis vaccines: present status.
Advances in biotechnological processes·1990
Vaccination against Brucella.
Advances in biotechnological processes·1990
Production of Marek's disease vaccine.
Advances in biotechnological processes·1990
Two undescribed bisabolane-type sesquiterpenoids from the endophytic fungus Penicillium herquei.
Journal of Asian natural products research·2026
The relevance of cannabinoid receptor 2 in the central nervous system: an update over the last 3 years.
Frontiers in behavioral neuroscience·2026
Do sigma-1 receptor agonists offer therapeutic promise for Alzheimer's disease?
Expert opinion on pharmacotherapy·2026
Protective Effects of Geraniol in Rheumatoid Arthritis Through Attenuation of Inflammation and Oxidative Stress.
Endocrine, metabolic & immune disorders drug targets·2026